Fertility Testing: When to Get Tested, What the Results Mean, and What to Do Next

Fertility testing is a critical step for any couple who has been trying to conceive without success — and increasingly, for proactive individuals who want to understand their reproductive health before beginning to try. Modern fertility tests provide unprecedented insight into egg reserve, sperm quality, hormonal function, and structural health, allowing for informed decisions and targeted interventions.

This comprehensive guide walks through the full landscape of fertility testing: when to get tested, what each test measures, how to interpret results, and what your options are depending on what the testing reveals.

When Should You Consider Fertility Testing?

Standard medical guidance recommends seeking fertility evaluation after:

• 12 months of regular unprotected intercourse without conception for women under 35
• 6 months for women 35–39
• 3 months for women 40 and over
• Immediately for couples with known risk factors (PCOS, endometriosis, previous STIs, male factor history, irregular cycles, prior pelvic surgery, testicular issues)

These timelines reflect the statistical probability of conception for fertile couples — approximately 85% will conceive within 12 months of trying. However, there's growing support for earlier proactive testing, particularly given the increasing age at which many people are starting families.

Many fertility specialists now advocate for a fertility awareness assessment — including AMH testing, semen analysis, and hormonal profile — for anyone planning to start a family in the next 1–2 years, regardless of whether they've begun trying. This proactive approach identifies potential issues early, when intervention options are broadest.

Female Fertility Tests: What They Measure and What They Mean

Anti-Müllerian Hormone (AMH) Test

AMH is produced by the small follicles in the ovaries and is currently the best available blood marker of ovarian reserve — the quantity of eggs remaining. Unlike other hormonal tests, AMH can be measured on any day of the cycle, making it accessible and convenient.

AMH interpretation:

• High AMH (>4.0 ng/mL): May indicate PCOS or high ovarian reserve
• Normal AMH (1.0–4.0 ng/mL): Indicates adequate ovarian reserve for age
• Low-normal AMH (0.5–1.0 ng/mL): Suggests diminished reserve — warrants monitoring and may influence timing of treatment decisions
• Very low AMH (<0.5 ng/mL): Indicates significantly reduced ovarian reserve — fertility specialist input is recommended

Important caveat: AMH measures quantity, not quality. Even with normal or high AMH, egg quality issues can impair fertility — particularly with advancing age. Conversely, women with low AMH have conceived naturally and through IVF with their own eggs.

Day 2–3 Hormonal Blood Panel

Measured at the beginning of the menstrual cycle (days 2–3), this panel typically includes:

• FSH (follicle-stimulating hormone): Elevated FSH indicates the pituitary is working harder to stimulate egg development — a sign of reduced ovarian reserve. High day-3 FSH is associated with poorer fertility prognosis.
• LH (luteinising hormone): Elevated LH relative to FSH suggests PCOS. Low LH can indicate hypothalamic dysfunction.
• Oestradiol (E2): Elevated E2 on day 3 can suppress FSH artificially, masking an underlying elevated FSH — an important consideration in interpreting the full panel.
• Prolactin: Elevated prolactin (hyperprolactinaemia) can suppress ovulation. Causes range from medications to benign pituitary tumours (prolactinoma).
• Thyroid function (TSH, T4): Thyroid disorders — both hypothyroidism and hyperthyroidism — significantly impair fertility and are frequently underdiagnosed. Optimal TSH for conception is generally considered <2.5 mIU/L.

Antral Follicle Count (AFC)

Performed by transvaginal ultrasound, AFC directly counts the small antral follicles visible in both ovaries — these represent the pool of follicles potentially available for recruitment in that cycle. AFC correlates with AMH and provides complementary information about ovarian reserve. It also allows visualisation of the uterus and identification of structural issues.

Progesterone Test (Mid-Luteal)

A blood progesterone level measured at approximately day 21 (or 7 days after presumed ovulation in irregular cycles) confirms whether ovulation actually occurred that cycle. A progesterone level above approximately 3 ng/mL (or 10 nmol/L) suggests ovulation occurred; levels above 10 ng/mL typically confirm adequate ovulation.

Structural Fertility Tests

Hysterosalpingography (HSG)

HSG is an X-ray procedure in which contrast dye is injected through the cervix to visualise the uterine cavity and fallopian tubes. It is primarily used to assess whether the fallopian tubes are open (patent) — blocked tubes prevent egg-sperm meeting and are a significant cause of female infertility.

HSG also provides information about the shape of the uterine cavity, identifying fibroids, polyps, or structural abnormalities that might impair implantation. Notably, some studies show a mild fertility-enhancing effect of HSG itself — the flushing action of the dye may clear minor blockages or enhance tube receptivity.

Saline Infusion Sonography (SIS)

SIS involves injecting saline into the uterine cavity via ultrasound to better visualise its interior. It's particularly useful for identifying intrauterine polyps, fibroids, or adhesions that might not be visible on standard ultrasound.

Hysteroscopy

A camera is inserted directly into the uterus via the cervix under anaesthesia, providing direct visualisation of the uterine cavity. It is the gold standard for assessing intrauterine abnormalities and can be simultaneously diagnostic and therapeutic (polyps or adhesions can be removed during the same procedure).

Laparoscopy

A surgical procedure involving a camera inserted through the abdomen to directly visualise the pelvic organs. Laparoscopy is the definitive diagnostic test for endometriosis — a condition affecting approximately 10% of women that cannot be reliably detected through blood tests or standard imaging. It can also identify and treat ovarian cysts, adhesions, and tubal blockages.

Semen Analysis: The Most Important Male Fertility Test

Male factor infertility accounts for approximately 40–50% of all cases. A semen analysis is the cornerstone of male fertility testing and should be performed early in any fertility evaluation — it is non-invasive, inexpensive, and provides essential diagnostic information.

Standard semen analysis measures:

• Volume: Normal ≥1.5 mL. Low volume may indicate ejaculatory duct obstruction or retrograde ejaculation.
• Concentration (count): Normal ≥16 million sperm per mL. Below 16 million is oligospermia.
• Total motility: Normal ≥42% motile sperm. Below this is asthenospermia.
• Progressive motility: Normal ≥30% progressively motile (moving forward). This is the most functionally important motility parameter.
• Morphology (strict/Kruger criteria): Normal ≥4% normal forms. Even very low morphology (1-2%) can still result in natural conception, though IVF success rates are affected at very low levels.
• Total motile sperm count (TMSC): Volume × concentration × progressive motility. TMSC <10 million is associated with reduced natural fertility; <1 million typically requires ICSI.

When to repeat semen analysis: Sperm production takes approximately 74 days (spermatogenesis cycle). An abnormal result should always be confirmed with a repeat test 2–3 months later, as a single result can be affected by recent illness, stress, heat exposure, or substance use.

Advanced Fertility Tests

Sperm DNA Fragmentation Testing: Standard semen analysis does not assess sperm DNA integrity. High sperm DNA fragmentation is associated with recurrent miscarriage, failed IVF cycles, and poor fertilisation rates. Testing is recommended for couples with unexplained infertility, recurrent miscarriage, or failed IVF/ICSI cycles.

Genetic Testing (Karyotyping): Chromosomal abnormalities can cause repeated miscarriage, failed implantation, or severe semen quality issues. Karyotyping of both partners is considered in cases of recurrent pregnancy loss or severe male factor infertility.

Immunological Testing: Anti-sperm antibodies can impair sperm function and fertilisation. Natural killer cell testing is controversial but sometimes performed in recurrent implantation failure cases.

ERA (Endometrial Receptivity Analysis): A biopsy-based test that analyses gene expression in the uterine lining to identify the optimal window for embryo transfer in IVF. Used in recurrent implantation failure where the uterine timing is suspected to be "off."

Interpreting Abnormal Fertility Test Results

Abnormal fertility test results are common — and they don't necessarily mean you can't conceive. They mean you have more information with which to make decisions.

Key points for interpreting results:

• A single abnormal result rarely tells the full story — patterns across multiple tests provide more meaningful clinical information
• Many conditions identified through fertility testing are treatable (thyroid disorders, vitamin D deficiency, structural issues, lifestyle-modifiable sperm parameters)
• The goal of fertility testing is not to generate anxiety but to identify actionable opportunities for improvement
• Fertility specialists interpret results in context — your age, cycle history, partner's results, and medical history all matter

What to Do While Awaiting Fertility Test Results

The period of fertility investigation is an ideal time to optimise foundational fertility health through nutrition and supplementation. Regardless of what testing reveals, the following supports reproductive health:

• Methylfolate supplementation for both partners
• Vitamin D optimisation (test and supplement if deficient)
• CoQ10 for egg mitochondrial support (particularly relevant if AMH or AFC shows reduced reserve)
• Antioxidant support (vitamins C and E, selenium) for both egg and sperm quality
• Fertility lubricant (Conceive Plus) for sperm-safe intimacy during the testing period

Conceive Plus prenatal vitamins and fertility supplements provide clinically informed nutritional support for both partners through the testing journey and beyond.

Frequently Asked Questions: Fertility Testing

Q: What is the most important fertility test for women?
A: AMH and antral follicle count (AFC) provide the most actionable information about ovarian reserve. Combined with a Day 2–3 hormonal panel and thyroid function, these tests provide a comprehensive picture of female fertility status. For women with cycle irregularities, ultrasound evaluation is also essential.

Q: Is semen analysis accurate for predicting male fertility?
A: Semen analysis is the best available fertility test for men but has limitations — it assesses quantity and motility but not sperm DNA integrity or fertilising ability. A normal semen analysis does not guarantee natural conception; an abnormal one does not make it impossible. Sperm DNA fragmentation adds an important additional dimension when standard results are normal but fertility issues persist.

Q: How long does it take to get fertility test results?
A: Blood tests (AMH, hormonal panel) typically return results within 3–7 days. Semen analysis results usually return within 1–3 days. Structural assessments (HSG, SIS, hysteroscopy) provide information during or immediately after the procedure.

Q: Can fertility tests be wrong?
A: All tests have sensitivity and specificity limitations. AMH can vary slightly between labs. Single semen analysis results can be affected by temporary factors. Structural assessments can miss subtle abnormalities. Repeating tests and cross-referencing multiple data points reduces error.

Q: Does a low AMH mean I can't get pregnant?
A: No. AMH indicates ovarian reserve quantity, not quality. Women with low AMH have conceived naturally and through IVF. Low AMH does influence how the ovaries respond to stimulation in IVF (fewer eggs may be retrieved) and may indicate a tighter timeline for trying to conceive. A specialist consultation is warranted to understand what a low AMH means for your specific situation.

Q: Does Conceive Plus help while undergoing fertility testing?
A: Yes. Conceive Plus fertility supplements and prenatal vitamins provide clinically dosed nutritional support that benefits reproductive health regardless of what testing reveals. Many users report taking Conceive Plus throughout their fertility investigation period — supporting egg quality, hormonal balance, and sperm health while awaiting results and pursuing appropriate interventions.

Q: When should a couple seek a second opinion after fertility testing?
A: If the results are complex, if recommended treatments feel uncertain, or if significant interventions like IVF are proposed, a second specialist opinion is entirely appropriate. Many fertility specialists encourage it. Your reproductive health decisions deserve the most informed guidance available.

Conclusion: Knowledge Is the Foundation of Fertility Action

Fertility testing is not about confronting worst-case scenarios — it's about gaining the knowledge needed to make smart, timely decisions about your reproductive health. Modern fertility testing provides remarkable insight, and most conditions identified through testing are either treatable or at minimum actionable.

Whatever your testing reveals, there is always a next step. Conceive Plus supports that journey — with the nutritional foundation your fertility health needs throughout investigation, optimisation, and treatment. Explore the full Conceive Plus range at conceiveplus.hk.